Samatasvir

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Hepatitis C InfectionChronic Hepatitis C Virus

Phase 1

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

CompletedNCT01813552

Merck Sharp & Dohme LLCChronic Hepatitis C Infection

Start: 2013-02-28End: 2013-03-31Updated: 2016-01-22

Phase 2

Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005)

CompletedNCT01852604

Merck Sharp & Dohme LLCChronic Hepatitis C Virus

Start: 2013-03-31End: 2015-04-30Updated: 2015-04-23